# InterAct Therapeutics, Inc. — Form D

InterAct Therapeutics, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-21. The offering totals $2.0M, of which $250K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2026-07-21
- Form: D
- Accession: 0002107143-26-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $250K
- Remaining: $1.8M
- Investors: 1
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-591571

## Issuer

- Name: InterAct Therapeutics, Inc.
- CIK: 0002107143
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3060 PEGASUS PARK DRIVE BUILDING 6, DALLAS, TX, 75247
- Phone: 2107102867

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Isaac Chan | Related Person | Dallas, TX |
| Daniel Hargrove | Related Person | Dallas, TX |

## More

- [CIK 2107143 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2107143&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002107143-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.